Stay in touch with NCATS by connecting via social media, joining our listserv for frequent announcements, and subscribing to our monthly e-newsletter.
Explore the full spectrum of translational science, including NCATS' role in transforming knowledge into treatments.
Review a list of all the innovative programs and initiatives that NCATS supports.
NCATS-funded team creates artificial intelligence for mobile devices to improve medication adherence.
Doctoral students use NCATS resources to investigate promising disease therapies for cancers and tuberculosis.
CTSA Program-funded researchers are studying natural disease resistance to identify therapeutic targets that help prevent or treat age-associated diseases.
Hear rare disease patients and caregivers talk about the challenges they face and how NIH’s collaborative research efforts offer hope.
Learn about NCATS’ new rare diseases patient video series, a possible treatment for Parkinson’s and Gaucher, a CTSA Program training success, and more.
Scholar Receives Grant
CTSA Program enables study of how a protein could prevent stem cell damage.
CTSA Program support enables clearest-ever image of key enzyme in cancer, aging.
Christopher P. Austin, M.D.
Petra Kaufmann, M.D., M.Sc., director of the NCATS Office of Rare Diseases Research and Division of Clinical Innovation, discusses how CTSA Program support is speeding the translation of research discoveries into health benefits. View the video.
Learn more about all the ways that potential grantees, partners and collaborators can access NCATS support to advance translational science.
More News & Events …